The FDA approved Amgen’s Epogen/Procrit for the treatment of anemia
On Apr. 1, 1993, the FDA approved Amgen’s Epogen/Procrit for the treatment of anemia due to the effects…
The FDA approved use of a new haemophilus b conjugate vaccine for infants and children
On Mar. 30, 1993, the U.S. Food and Drug Administration (FDA) approved a new Haemophilus b conjugate vaccine,…
FDA declared genetically-engineered foods are not inherently dangerous and do not require special regulation
In 1993, the U.S. Food and Drug Administration (FDA) declared genetically-engineered foods are not inherently dangerous and do…
FDA added new CBER reviewers to streamline biologics review and user fees were enacted
In 1993, The U.S. Food and Drug Administration (FDA) added new CBER reviewers to streamline biologics review. User…
Genentech drug Nutropin was approved
In 1993, Genentech drug Nutropin was approved by the U.S. Food and Drug Administration (FDA).
Biotechnology | Disease | FDA | Life Science News | Oncology | Therapeutics
Taxol (paclitaxel) approved by the FDA for the treatment of ovarian cancer that has failed other therapy
On Dec. 18, 1992, Taxol (paclitaxel), an anticancer drug extracted from the bark of the Pacific yew, received…
Japanese encephalitis virus vaccine inactivated was licensed
On Dec. 10, 1992, the Japanese encephalitis (JE) virus vaccine inactivated (JE-Vax by Research Foundation for Microbial Diseases…
PathoGenesis was founded
On Sept. 3, 1992, PathoGenesis Corp. was founded by Robert Nowinski. The company, based in Seattle, developed an…
Agriculture | Biotechnology | FDA | Life Science News | USDA
FDA announced new food labeling rules
On Feb. 29, 1992, the U.S. Food and Drug Administration (FDA)Â announced new food labeling rules. The purpose…
Prescription Drug User Fee Act required drug and biologics manufacturers to pay fees for product applications, and other services
In 1992, President George Bush signed the Prescription Drug User Fee Act (PDUFA) and under the Clinton administration,…
University of Iowa Research Foundation received U.S. patents for CMV promoter
In 1992, the University of Iowa (UI) Research Foundation received its first U.S. patent on the CMV promoter,…
Diphtheria and tetanus toxoids and acellular pertussis vaccine was licensed for use
On Dec. 17, 1991, the Diphtheria and tetanus toxoids and acellular pertussis vaccine (Acel-Imune by Lederle) was licensed…
Biotechnology | Disease | FDA | HIV | Life Science News
Bristol-Myers’ VIDEX (didanosine) was approved by the US Food and Drug Administration
On Oct. 9, 1991, Bristol-Myers’ VIDEX (didanosine) was approved by the U.S. Food and Drug Administration for the…
Cellpro announced its initial public offering
On Aug. 26, 1991, Cellpro announced its initial public offering. CellPro, founded in Bothell, developed the CEPRATE SC…
ICOS Corporation completed its IPO
On Jun. 6, 1991, ICOS completed its IPO at at $8.00 per share for a total of $36…
Immunex received FDA approval to market Leukine (GM-CSF) in the U.S.
In March 1991, Immunex announced it had received U.S. Food and Drug Administration (FDA) approval to market Leukine…
FDA approved White blood cell colony-stimulating factors (G-CSF and GM-CSF)
On Feb. 22, 1991, the Food and Drug Administration (FDA) announced that it had approved Amgen’s two white…
The policy for protection of human subjects in research was adopted by more than a dozen federal entities
In 1991, the policy for protection of human subjects in research, promulgated in 1981 by the U.S. Food…
Regulations published to Accelerate the Review of Drugs for life-threatening diseases
In 1991, regulations published to Accelerate the Review of Drugs for life-threatening diseases. In Decemebr, 1992, the FDA…
Bristol-Myers’ cardiovascular medicines, PRAVACHOL (pravastin sodium) and MONOPRIL (fosinopril sodium) approved by the US Food and Drug Administration
In 1991, Bristol Myers Squibb’s cardiovascular medicines, PRAVACHOL (pravastin sodium) and MONOPRIL (fosinopril sodium) were approved by the…
The FDA approved PRP-OMP for routine administration to infants beginning at 2 months of age
On Dec. 13, 1990, the U.S. Food and Drug Administration (FDA) approved Haemophilus b Conjugate Vaccine (Meningococcal Protein…
The Safe Medical Devices Act was passed
On Nov. 28, 1990, the Safe Medical Devices Act was passed, requiring nursing homes, hospitals, and other facilities…
Nutrition Labeling and Education Act required all packaged foods to bear nutrition labeling
On Nov. 8, 1990, the Nutrition Labeling and Education Act was signed into law by President George H….
BOTOX(R) cosmetic (onabotulinumtoxinA) approved by the FDA
On Dec. 29, 1989, the U.S. Food and Drug Administration (FDA) approved Oculinum’s (onabotulinumtoxinA) for treatment of strabismus…
FDA issued a nationwide recall of all OTC dietary supplements containing 100 milligrams or more of L-Tryptophan
On Nov. 24, 1989, the U.S. Food and Drug Administration (FDA) issued a nationwide recall of all over-the-counter…
Recombinant hepatitis B vaccine (Engerix-B by SmithKline Beecham) was licensed
On Aug. 28, 1989, a second recombinant hepatitis B vaccine, Engerix-B (SmithKlineBeecham), was approved for use in the…
The FDA approved the hormone, called Epogen
On Jun. 1, 1989, the FDA approved Amgen’s Epogen/Procrit for the treatment of anemia associated with chronic renal…
Bristol-Myers’ PARAPLATIN (carboplatin) was approved for the treatment of recurrent ovarian cancer
On Mar. 3, 1989, the U.S. Food and Drug Administration (FDA) approved Bristol-Myers’ PARAPLATIN (carboplatin) for the treatment…
Carboplatin, a drug related to cisplatin, was approved by the Food and Drug Administration
In 1989, carboplatin, a drug related to cisplatin, was approved by the FDA for initial treatment of advanced…
Transgenic fast-growing salmon were created
In 1989, transgenic fast-growing salmon were created. In 2015, the U.S. Food and Drug Administration (FDA) approved a…